Orgad Laub
Founder and CEO at Sealantium Medical- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Sealantium Medical
-
Israel
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
Founder and CEO
-
2011 - Present
Rosh HaAyin, Center District, Israel Sealantium Medical is developing a revolutionary surgical device, combining a polymeric degradable film with fibrin sealant to effectively manage bleeding and bodily fluid leakage during surgeries. sFilm-FS™ will be the first, innovative hemostatic and sealing patch to address the more than $1 billion surgical sealant market in almost a decade. For more information, please visit: https://sealantium-med.com
-
-
-
Omrix Biosurgery Israel
-
Israel
-
Biotechnology Research
-
200 - 300 Employee
-
Vice President Research & Business Development.
-
2002 - 2010
Managed a 40-person Research and Development department that developed and registered Plasma-derived products including Immunoglobulins (IVIG) Fibrin Sealant (Quikseal) and a Fibrin Patch (Evarrest). Responsible for the development of Omrix immunoglobulin pipeline which turned into a leading business of the company (with sales of 30 MM/year)
-
-
-
YEDA - Technology Transfer Company of Weizmann Institute of Science
-
Israel
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Vice President Science & Technology
-
1995 - 2001
Israel Chief Scientist of Yeda, responsible for the commercialization of numerous inventions generated in The Weizmann Institute of Science. Yeda was among the five most successful Technology Transfer Academic Institutions worldwide generating hundreds of million dollars in revenues.
-
-
-
Weizmann Institute of Science
-
Israel
-
Research
-
700 & Above Employee
-
Associate Professor Dept. of Molecular Genetics and Virology
-
1990 - 1995
Published over 50 papers on the molecular biology of viruses including Hepatitis B, Polyoma, Simian Virus 40, and more.
-
-
Senior Scientist
-
1990 - 1995
Dept. of Molecular Genetics and Virology. Research subject: Regulation of Hepatitis B Gene Expression. In the frame of these studies, OL invented a novel Hepatitis B vaccine which is used to immunize babies and immunodeficient people against Hepatitis B infection.
-
-
-
Israel Defense Forces
-
Israel
-
Armed Forces
-
700 & Above Employee
-
Army Service
-
Jan 1966 - Dec 1969
-
-
Education
-
University of California, San Francisco
Post doctoral Fellow, School of Medicine Dept. of Biochemistry & Biophysic -
Weizmann Institute of Science
Ph.D Studies (with distinction), Dept. of Genetics and Virolog -
Weizmann Institute of Science
M.Sc. Studies (with Distinction), Dept. of Genetics -
Tel Aviv University
B.Sc. Studies, Life Sciences